ketorolac tromethamine has been researched along with dinoprostone in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (50.00) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buchanan, W; Doyle, MJ; Goodale, MB; Haigh, S; Jeffcoat, MK; Meredith, MP; Nelson, SL; Reddy, MS; Wehmeyer, KR | 1 |
| Alavi, FK; Hoff, KK; Zawada, ET | 1 |
| Felsen, D; Marion, DN; Miller, L; Perlmutter, A; Trimble, LA; Vaughan, ED | 1 |
| Buchanan, W; Cavanaugh, PF; Doyle, MJ; Jeffcoat, MK; Meredith, MP; Reddy, MS | 1 |
| Burger, J; Conlon, P; Pasloske, K | 1 |
| Brown, P; Heasman, PA; Lauffart, B; Preshaw, PM; Zak, E | 1 |
| Alton, T; Hargreaves, KM; Roszkowski, MT; Swift, JQ | 1 |
| Brahim, JS; Dionne, RA; Gordon, SM; Kent, A; Rowan, J | 1 |
| Amico, LM; Bucci, FA; Waterbury, LD | 1 |
| Walters, T | 1 |
| Bucci, FA; Waterbury, LD | 1 |
| Calcutt, MW; Kim, SJ; Schoenberger, SD; Sheng, J | 1 |
| Cherney, E; Kim, SJ; Schoenberger, SD; Shah, R; Sheng, J | 1 |
| Mo, Z; Wang, F; Wang, Z | 1 |
7 trial(s) available for ketorolac tromethamine and dinoprostone
| Article | Year |
|---|---|
A comparison of topical ketorolac, systemic flurbiprofen, and placebo for the inhibition of bone loss in adult periodontitis.
Topics: Adult; Alveolar Bone Loss; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Dental Plaque Index; Dinoprostone; Double-Blind Method; Female; Flurbiprofen; Gingival Crevicular Fluid; Humans; Interleukin-1; Ketorolac Tromethamine; Male; Middle Aged; Mouthwashes; Periodontal Index; Periodontitis; Radiography; Statistics, Nonparametric; Subtraction Technique; Tolmetin; Treatment Outcome; Tromethamine | 1995 |
Coordinate production of PGE2 and IL-1 beta in the gingival crevicular fluid of adults with periodontitis: its relationship to alveolar bone loss and disruption by twice daily treatment with ketorolac tromethamine oral rinse.
Topics: Adult; Alveolar Bone Loss; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Dinoprostone; Female; Gingival Crevicular Fluid; Humans; Interleukin-1; Ketorolac Tromethamine; Linear Models; Male; Middle Aged; Mouthwashes; Periodontitis; Radiographic Image Interpretation, Computer-Assisted; Subtraction Technique; Tolmetin; Tromethamine | 1998 |
Effects of ketorolac tromethamine mouthrinse (0.1%) on crevicular fluid prostaglandin E2 concentrations in untreated chronic periodontitis.
Topics: Adult; Aged; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Dental Plaque Index; Dinoprostone; Double-Blind Method; Drugs, Investigational; Female; Gingival Crevicular Fluid; Humans; Ketorolac Tromethamine; Male; Middle Aged; Mouthwashes; Periodontal Index; Periodontitis; Tolmetin; Treatment Outcome; Tromethamine | 1998 |
Peripheral prostanoid levels and nonsteroidal anti-inflammatory drug analgesia: replicate clinical trials in a tissue injury model.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Dinoprostone; Double-Blind Method; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Ketorolac Tromethamine; Male; Mandible; Microdialysis; Molar, Third; Prostaglandins; Thromboxane B2; Tooth Extraction | 2002 |
Prostaglandin E2 inhibition and aqueous concentration of ketorolac 0.4% (acular LS) and nepafenac 0.1% (nevanac) in patients undergoing phacoemulsification.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Benzeneacetamides; Biological Availability; Chromatography, High Pressure Liquid; Dinoprostone; Double-Blind Method; Humans; Immunoenzyme Techniques; Ketorolac Tromethamine; Mass Spectrometry; Phacoemulsification; Phenylacetates | 2007 |
Aqueous prostaglandin E(2) of cataract patients at trough ketorolac and bromfenac levels after 2 days dosing.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Benzophenones; Bromobenzenes; Cataract Extraction; Dinoprostone; Double-Blind Method; Female; Humans; Ketorolac Tromethamine; Male; Middle Aged; Ophthalmic Solutions; Preoperative Care | 2009 |
Reduction of interleukin 8 and platelet-derived growth factor levels by topical ketorolac, 0.45%, in patients with diabetic retinopathy.
Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Diabetic Retinopathy; Dinoprostone; Double-Blind Method; Female; Humans; Immunoenzyme Techniques; Interleukin-8; Ketorolac Tromethamine; Male; Middle Aged; Ophthalmic Solutions; Platelet-Derived Growth Factor; Prospective Studies; Vitrectomy; Vitreous Body | 2014 |
7 other study(ies) available for ketorolac tromethamine and dinoprostone
| Article | Year |
|---|---|
Renal hemodynamic effects of chronic ketorolac tromethamine treatment in aged lean and obese Zucker rats.
Topics: Aging; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Dinoprostone; Drug Combinations; Female; Glomerular Filtration Rate; Ketorolac Tromethamine; Kidney; Obesity; Rats; Rats, Zucker; Renal Circulation; Renal Plasma Flow, Effective; Time Factors; Tolmetin; Tromethamine | 1995 |
Toradol, an NSAID used for renal colic, decreases renal perfusion and ureteral pressure in a canine model of unilateral ureteral obstruction.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colic; Depression, Chemical; Dinoprostone; Dogs; Drug Combinations; Glomerular Filtration Rate; Ketorolac Tromethamine; Kidney Diseases; Pressure; Renal Circulation; Thromboxane-A Synthase; Tolmetin; Tromethamine; Ureter; Ureteral Obstruction | 1993 |
Plasma prostaglandin E2 concentrations after single dose administration of ketorolac tromethamine (Toradol) in dogs.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Dinoprostone; Dogs; Female; Ketorolac Tromethamine; Male; Time Factors; Tolmetin; Tromethamine | 1998 |
Effect of intra-articular versus systemic anti-inflammatory drugs in a rabbit model of temporomandibular joint inflammation.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bradykinin; Dexamethasone; Dinoprostone; Disease Models, Animal; Fever; Glucocorticoids; Inflammation Mediators; Injections, Intra-Articular; Injections, Intraperitoneal; Ketorolac Tromethamine; Male; Microdialysis; Rabbits; Reproducibility of Results; Temporomandibular Joint Disorders; Time Factors; Tolmetin | 1998 |
Re: Prostaglandin E(2) inhibition and aqueous concentration of ketorolac 0.4% and nepafenac 0.1% in patients undergoing phacoemulsification.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Benzeneacetamides; Chromatography, High Pressure Liquid; Dinoprostone; Humans; Immunoenzyme Techniques; Ketorolac Tromethamine; Phacoemulsification; Phenylacetates | 2007 |
Reduction of vitreous prostaglandin E2 levels after topical administration of ketorolac 0.45%.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Chromatography, High Pressure Liquid; Cyclooxygenase Inhibitors; Dinoprostone; Epiretinal Membrane; Humans; Immunoenzyme Techniques; Ketorolac Tromethamine; Middle Aged; Prospective Studies; Retinal Perforations; Tandem Mass Spectrometry; Vitrectomy; Vitreous Body | 2014 |
The Determination and Clinical Significance of Prostaglandin E2 in Blood and Urine of Patients with Renal Colic.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Dinoprostone; Female; Humans; Ketorolac Tromethamine; Male; Middle Aged; Renal Colic; Treatment Outcome; Young Adult | 2018 |